跳至主要内容
临床试验/NCT07543926
NCT07543926尚未招募不适用

Evaluation Of Intralesional Platelet-Rich Fibrin Versus Intralesional Vitamin D In Treatment Of Common Warts

Sohag University1 个研究点 分布在 1 个国家目标入组 70 人开始时间: 2026年4月6日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
尚未招募
入组人数
70
试验地点
1
主要终点
treatment of common wart by PRF injection ( Mild response: < 50% reduction in lesion size , Moderate response: ≥ 50% reduction in lesion size , to measure the change in lesion size , is the patient satisfied or not )

研究概览

简要总结

this study aims to compare the efficacy and safety of platelet rich fibrin injection versus intralesional vitamin D injection in the treatmentof common warts. PRF, as an autologous biological material , may enhance tissue regeneration and immune response.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • - Age more than or equal to 18 years
  • Clinically and dermoscopically confirmed Common warts of both sex
  • patient not receiving previous treatment at least one month before recruitment in our study
  • Single or multiple lesions suitable for injection.

排除标准

  • Chronic Systemic desise (DM , HTN , Autoimmune , immunosuppressive disorders eg , lupus , renal or hepatic failure ) or Hematologic Conditions (anemia : hemoglobin level below 10 g/dl , thrombocytopenia : platelet count below 150,000 /µL ) Infectious Diseases , Local bacterial or fungal infection at the lesions .
  • Pregnancy, Lactation , patients who has hypersensitivity of vitamin D .

研究组 & 干预措施

group 1 PRF injection

Active Comparator

干预措施: PRF group (Biological)

group 2 vitamin D injection

Active Comparator

干预措施: Vitamin D (Drug)

结局指标

主要结局

treatment of common wart by PRF injection ( Mild response: < 50% reduction in lesion size , Moderate response: ≥ 50% reduction in lesion size , to measure the change in lesion size , is the patient satisfied or not )

时间窗: 1 session every 2 weeks for 3 months

treatment of common wart by intralesional injection of PRF

changes in common warts after treatment by PRF (measuring complete clearance and recurrence of the lesions ,asking about patient satisfaction )

时间窗: 6 months after the last session

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Bassma Alaaeldin Mohamed

Dermatology , Venerology and Andrology Resident at Sohag University Hospital

Sohag University

研究点 (1)

Loading locations...

相似试验